Status:
COMPLETED
Evaluation of MyoStrain™ in Clinical Practice
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Cardiac Failure
Coronary Artery Disease
Eligibility:
All Genders
Brief Summary
Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice
Detailed Description
Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice to determine how the use may alter treatment decisions and clinical outcomes in patients who are undergoing cardiac MRI.
Eligibility Criteria
Inclusion
- Patients already scheduled for diagnostic testing with commercially available imaging modality (cardiac MRI)
- The patient population will include (but not limited to), those being evaluated for heart disease and heart failure that may be related to vascular disease (coronary artery disease), drug related heart failure (chemotherapy, alcohol), inflammatory systemic conditions (sarcoidosis, amyloidosis, lupus), myocarditis, and/or infectious etiologies
- Provided written informed consent
Exclusion
- Contraindication to Magnetic Resonance Imaging
Key Trial Info
Start Date :
April 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 15 2019
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03825224
Start Date
April 15 2019
End Date
November 15 2019
Last Update
November 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Kansas Medical Center
Kansas City, Kansas, United States, 66160